ZSIG(SH:600313)2024-04-26 07:38Financial Performance - The company's operating revenue for Q1 2024 was ¥847,139,135.06, representing a decrease of 30.38% compared to the same period last year[4] - Net profit attributable to shareholders was ¥45,459,020.02, an increase of 16.24% year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥17,021,405.62, down 45.06% year-on-year, primarily due to reduced profits in the pesticide business[7] - The company reported a net profit margin of approximately 3.1% for Q1 2024, compared to 4.5% in Q1 2023[18] - The total profit for Q1 2024 reached CNY 75,979,700.18, compared to CNY 67,852,689.16 in Q1 2023, indicating an increase of about 15.5%[19] - The net profit attributable to shareholders of the parent company for Q1 2024 was CNY 45,459,020.02, an increase from CNY 39,106,521.34 in Q1 2023, representing a growth of approximately 8.5%[20] - Basic and diluted earnings per share for Q1 2024 were CNY 0.0420, compared to CNY 0.0361 in Q1 2023, reflecting an increase of about 16.3%[20] Cash Flow and Liquidity - The net cash flow from operating activities was -¥107,402,823.12, a decline of 190.81% compared to the previous year[7] - The company reported a significant decrease in cash received from sales, totaling CNY 957,929,912.89 in Q1 2024, down from CNY 1,371,156,956.85 in Q1 2023, reflecting a drop of approximately 30%[23] - The company's total cash and cash equivalents at the end of Q1 2024 were CNY 751,127,371.34, down from CNY 903,454,021.00 at the end of Q1 2023, a decrease of approximately 16.8%[24] - Investment activities resulted in a net cash outflow of CNY -315,112,715.45 for Q1 2024, compared to CNY -277,632,780.51 in Q1 2023, indicating an increase in cash outflow of about 13.5%[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,785,903,013.02, a decrease of 0.96% from the end of the previous year[5] - Total liabilities decreased to RMB 1,837,606,381.10 from RMB 1,955,833,116.04, a decline of 6.0%[15] - Shareholders' equity attributable to shareholders was ¥1,909,688,236.17, an increase of 2.47% from the end of the previous year[5] - Shareholders' equity increased to RMB 2,948,296,631.92 from RMB 2,876,380,098.85, an increase of 2.5%[15] Operational Efficiency - Total operating costs for Q1 2024 were RMB 821,270,032.51, down 29.2% from RMB 1,161,513,861.90 in Q1 2023[18] - Cash and cash equivalents decreased to RMB 780,355,499.07 from RMB 1,206,136,311.20 as of December 31, 2023, representing a decline of 35.2%[13] - Accounts receivable increased to RMB 408,804,876.78 from RMB 286,241,474.07, reflecting a growth of 42.8%[13] - Inventory decreased slightly to RMB 718,841,318.79 from RMB 727,746,909.37, a reduction of 1.2%[13] Government Support and Future Plans - The company received government subsidies amounting to ¥19,221,799.12, which are closely related to its normal business operations[6] - The company plans to focus on market expansion and new product development in the upcoming quarters[12] Research and Development - Research and development expenses for Q1 2024 were CNY 12,813,356.93, down from CNY 17,753,485.02 in Q1 2023, representing a decrease of approximately 27.8%[19] Financial Ratios - The weighted average return on equity increased by 0.18 percentage points to 2.41%[4] - The company's financial expenses for Q1 2024 were CNY 2,281,806.93, compared to a negative CNY -611,714.88 in Q1 2023, indicating a significant increase in financial costs[19]